Clinical Trial Update: Role of Ivermectin Nanosuspension as Nasal Spray in Treatment of Persistant Post covid19 Anosmia [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update on an ivermectin nanosuspension nasal spray for persistent post-COVID-19 anosmia, currently in Phase 2/Phase 3 with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anosmia

Drugs mentioned

• Ivermectin nanosuspension nasal spray (ivermectin nanosuspension nasal spray)

Snippet

Sponsor: South Valley University | Conditions: Anosmia | Phase 2, Phase 3 | Status: UNKNOWN